The report provides a detailed understanding and analysis of how and why companies enter immunology partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors immunology technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.
Delivery of this report will take 1-3 days after purchase.
Complete report available @ http://www.lifescienceindustryresearch.com/immunology-partnering-terms-and-agreements.html.
Ride the Storm: Navigating Through Unstable Periods / Katerina Rudko (Belka G...
Immunology Deals Market Analysis & Research Partnering Terms & Agreements
1. IMMUNOLOGY PARTNERING TERMS AND AGREEMENTS
Published: March 2014
No of Pages: 1159
Single User PDF: US$ 2995
Corporate User PDF: US$ 14995
2. Immunology Partnering Terms and Agreements
The Immunology Partnering Terms and Agreements report provides comprehensive
understanding and unprecedented access to the immunology partnering deals and
agreements entered into by the worlds leading healthcare companies.
The report provides a detailed understanding and analysis of how and why companies
enter immunology partnering deals. The majority of deals are discovery or development
stage whereby the licensee obtains a right or an option right to license the licensors
immunology technology. These deals tend to be multicomponent, starting with
collaborative R&D, and commercialization of outcomes.
Understanding the flexibility of a prospective partner’s negotiated deals terms provides
critical insight into the negotiation process in terms of what you can expect to achieve
during the negotiation of terms. Whilst many smaller companies will be seeking details
of the payments clauses, the devil is in the detail in terms of how payments are
triggered – contract documents provide this insight where press releases do not.
Delivery of this report will take 1-3 days after purchase.
Complete report available @
http://www.lifescienceindustryresearch.com/immunology-partnering-terms-and-
agreements.html.
3. Immunology Partnering Terms and Agreements
This report contains over 1,000 links to online copies of actual immunology deals and
contract documents as submitted to the Securities Exchange Commission by companies
and their partners. Contract documents provide the answers to numerous questions
about a prospective partner’s flexibility on a wide range of important issues, many of
which will have a significant impact on each party’s ability to derive value from the deal.
The initial chapters of this report provide an orientation of immunology dealmaking and
business activities.
Chapter 1 provides an introduction to the report. Chapter 2 provides an overview of the
trends in immunology dealmaking since 2009 covering trends by year, deal type, stage of
development, technology type and therapeutic indication. In addition the chapter
includes an analysis of financial deal terms by stage at signing covering headline value,
upfront payment, milestone payments and royalty rates. Analysis includes median values
and distribution of values for each stage of development.
Chapter 3 provides a review of the leading immunology deals since 2009. Deals are
listed by headline value, signed by bigpharma, most active bigpharma, and most active
of all biopharma companies. Where the deal has an agreement contract published at the
SEC a link provides online access to the contract.
Delivery of this report will take 1-3 days after purchase.
Order a copy of this report at @
http://www.lifescienceindustryresearch.com/purchase?rname=3800.
4. Immunology Partnering Terms and Agreements
In conclusion, this report provides everything a prospective dealmaker needs to know
about partnering in the research, development and commercialization of immunology
technologies and products.
Benefits
Immunology Partnering Terms and Agreements provides the reader with the following
key benefits:
In-depth understanding of immunology deal trends since 2009
Access immunology deal headline, upfront, milestone and royalty data
Research hundreds of actual contracts between immunology partner companies
Comprehensive access to over 1,000 links to actual immunology deals entered into by
the world’s biopharma companies
Indepth review of immunology deals entered into by the leading fifty bigpharma
companies
Benchmark the key deal terms companies have agreed in previous deals
Identify key terms under which companies partner immunology opportunities
Uncover companies actively partnering immunology opportunities
Delivery of this report will take 1-3 days after purchase.
Inquire Before Buying @ http://www.lifescienceindustryresearch.com/inquire-before-
buying?rname=3800.
5. ABOUT US
LIFE SCIENCE INDUSTRY RESEARCH BRINGS TO YOU TO THE LATEST REPORTS IN MARKET
RESEARCH ON BIOTECHNOLOGY, DIAGNOSTICS, HEALTHCARE, MEDICAL DEVICES AND
PHARMACEUTICALS SEGMENTS FROM LEADING RESEARCH PUBLISHERS ACROSS THE
GLOBE. THESE REPORTS ALSO COVER DATA AND INFORMATION ON SUB-SEGMENTS AND
SECTORS UNDER THESE LIFE SCIENCES CATEGORIES.
CONTACT US (SALES@LIFESCIENCEINDUSTRYRESEARCH.COM / + 1 888 391 5441)
FOR ANY OF YOUR RESEARCH REQUIREMENTS OR TOPICS OF INTEREST. OUR SALES &
RESEARCH ASSOCIATES WILL BE HAPPY TO HELP YOU FIND RELEVANT MARKET DATA.
WEBSITE : WWW.LIFESCIENCEINDUSTRYRESEARCH.COM
Browse Latest Industry News, Updates, Trends,
Opportunities, Scenario all over the world @